Cégep de Lévis
QC, Canada
Cégep de Lévis: Advance your project with a research partnership
grant_single_labels|summary
grant_single|eligibleFinancing
- grant_single|noCondition
grant_single|deadlines
- grant_single|timelineUnspecified
grant_single|financingType
Researchers And Facilities
grant_single|eligibleIndustries
- grant_single|allIndustries
grant_single|grantors
- Cognit.ca
- Cégep de Lévis
grant_single|status
grant_card_status|open
grant_single_labels|preview
Get access to world-class expertise, facilities and IP when you form a partnership with a university, college or health institution. Use the partnership to help solve complex problems, build proofs-of-concept, improve processes and performance, validate y
grant_single_labels|projects
There are eligible projects for this grant:
- Validation of a rat model for IDB
- Immunogénicité d'un système de transformation cellulaire
- Mise au point d'essais in vitro afin de déterminer la métabolisation d'un médicament en phase de développement
- Engineering and bioavailability validation of precise and standardized new oncology nanoconstruction drug delivery systems
grant_single|admissibleProjectsExample
$120,000
Toronto
Validation of a rat model for Inflammatory Bowel Disease (IBD).
$200,000
Edmonton
Validation of bioavailability for a new oncology nanodrug delivery system.
$240,000
Ottawa
Engineering and validation of new oncology nanoconstruct drug delivery systems.
$140,000
Waterloo
Development of new in vitro assays for drug metabolism analysis.
$160,000
Montreal
Development of in vitro assays to determine drug metabolism during the developmental phase.
$144,000
Vancouver
Immunogenicity analysis of a cellular transformation system in partnership with UBC.
grant_single_labels|admissibility
The eligibility criteria for this grant include:
- Projects related to the development or validation of new drugs or therapies
- Projects focusing on cancer research, immunology, or inflammation
- Preference for projects that demonstrate potential for practical applications in healthcare
grant_eligibility_criteria|who_can_apply
Eligible types of companies for this grant include those involved in biotechnology, pharmaceuticals, and nutraceuticals. Companies focusing on probiotics, oncology drug delivery, and vaccine development may also qualify.
- Biotechnology companies
- Pharmaceutical companies
- Nutraceutical companies
- Probiotics-focused companies
- Oncology drug delivery companies
- Vaccine development companies
grant_eligibility_criteria|eligible_expenses
Eligible expenses for this grant include:
- Laboratory equipment and supplies
- Research materials
- Research assistant salaries
- Travel expenses related to the research project
grant_single_labels|criteria
For this grant, the evaluation and selection criteria include assessing the project's impact, feasibility, innovation, and alignment with program objectives.
- Impact of the project
- Feasibility of the project
- Level of innovation
- Alignment with program objectives
grant_single_labels|register
- Step 1: Review the eligibility criteria and guidelines for the grant.
- Step 2: Prepare a detailed research proposal outlining the project objectives, methodology, and budget.
- Step 3: Complete the application form and submit it within the specified deadline.
- Step 4: Await the evaluation process where the proposal will be reviewed for feasibility and impact.
- Step 5: Upon approval, manage the grant funds responsibly and execute the research project according to the proposed plan.
grant_single_labels|otherInfo
There is no additional information available for this grant.
Apply to this program
Grant Summary:
This grant focuses on the valorization of by-products from brown algae processing as prebiotics. Isabelle Fortier, the Principal Investigator, aims to investigate the potential of these by-products as valuable resources for prebiotic purposes.
Grant Details:
Isabelle Fortier, a researcher at Cégep de Lévis, is leading a project that aims to explore the valorization of by-products generated from brown algae processing. The grant, totaling $125,000, is focused on investigating the potential of these by-products as prebiotics, which can have significant implications for various industries and applications.
The project, spanning from 2018 to 2020, involves research activities to validate the efficacy and benefits of utilizing brown algae by-products as prebiotics. Prebiotics are known for their positive effects on gut health, digestion, and overall well-being. By repurposing these by-products, the project seeks to contribute to the development of sustainable and innovative solutions in the field of prebiotics.
Isabelle Fortier's research expertise and leadership in this area make her well-equipped to spearhead this project and drive meaningful outcomes. With the support of this grant, the exploration of brown algae by-products as prebiotics holds promise for advancing knowledge in the field and potentially opening up new avenues for sustainable resource utilization.
